Emily Atkins

About Dr Emily Atkins

Senior Research Fellow

Dr Emily R Atkins is a Senior Research Fellow in Health Systems Science at the George Institute for Global Health and a Conjoint Senior Lecturer at UNSW Sydney. She has expertise in economic evaluation, cardiovascular trials, and linked data analysis. Dr Atkins' recent focus has been on the health economics of blood pressure lowering medicines. She is interested in affordable and equitable improvements in cardiovascular medicines use globally. Dr Atkins is the health economist leading the economic evaluation of the NEXTGEN-BP randomised trial.

Dr Atkins is an Executive Committee member and Scientific Advisory Committee member of the Australian and New Zealand Alliance for Cardiovascular Trials (2018-present). She was a National Heart Foundation Australia Postdoctoral Research Fellow (2018) and World Heart Federation Emerging Leader (2017) working on blood pressure lowering clinical trials and access and affordability of cardiovascular medicines, including a feasibility study of adherence clubs for hypertension.

Emily completed her PhD (2015) at the University of Western Australia using linked administrative hospital morbidity, deaths, and pharmacy data to investigate the cost-effectiveness of cardiovascular medicines for secondary prevention of atherothrombotic disease.
 

Low-Intensity Monitoring for Mild-to-Moderate Acute Ischemic Stroke Is Cost Saving: Economic Evaluation for OPTIMISTmain

Stroke Date published:

The Association Between Migraine and Type 2 Diabetes Mellitus: A Narrative Review

International Journal of Preventive Medicine Date published:

Low-Intensity Monitoring for Mild-to-Moderate Acute Ischemic Stroke Is Cost Saving: Economic Evaluation for OPTIMISTmain

Stroke Date published:

Digital support for chronic dyspnoea management in primary care: protocol for the BREATHE (Breathlessness Rapid Evaluation and Therapy) cluster randomised controlled trial

BMJ Open Date published:

Related Readings